经泪小管引流联合D型硅胶管植入治疗急性泪囊炎
Treatment of acute dacryocystitis by translacrimal canalicular drainage and D-silicone intubation.
作者信息
He Jin-Jing, Gong Jing-Wen, Zhou Jia-Ni, Jiang Jin
机构信息
Center for Rehabilitation Medicine, Department of Ophthalmology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China.
Xianju People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital, Affiliated Xianju's Hospital, Hangzhou Medical College, Taizhou 317300, Zhejiang Province, China.
出版信息
Int J Ophthalmol. 2024 Sep 18;17(9):1628-1632. doi: 10.18240/ijo.2024.09.08. eCollection 2024.
AIM
To demonstrate the outcomes of translacrimal canalicular drainage using a lacrimal probe and intranasal drainage by D-silicone intubation for acute dacryocystitis (AD).
METHODS
This retrospective study included 23 patients with AD and had undergone abscess decompression with the use of lacrimal probe and intranasal drainage by D-silicone intubation between January 2019 and December 2022. Patients received abscess decompression and systemic antibiotic-corticosteroid from the time of diagnosis. D-silicone tube was inserted within 10d after diagnosis and removed 3-6mo after intubation. The procedure and outcomes of this method were evaluated.
RESULTS
All patients showed improvement of signs and symptoms of AD within 72h. No intraoperative and postoperative complications were observed. No recurrence of lacrimal sac abscesses occurred after D-silicone tube removed.
CONCLUSION
Lacrimal probe and D-silicone intubation appear to be a feasible, minimally invasive, safe, and effective method, which could be a reasonable choice in the treatment of AD.
目的
探讨使用泪道探针经泪小管引流联合D型硅胶管鼻腔引流治疗急性泪囊炎（AD）的效果。
方法
本回顾性研究纳入了2019年1月至2022年12月期间23例接受泪道探针脓肿减压联合D型硅胶管鼻腔引流治疗的AD患者。患者从诊断时起接受脓肿减压及全身抗生素 - 皮质类固醇治疗。诊断后10天内插入D型硅胶管，插管后3 - 6个月取出。评估该方法的操作过程及效果。
结果
所有患者在72小时内AD的体征和症状均有改善。未观察到术中及术后并发症。D型硅胶管取出后未发生泪囊脓肿复发。
结论
泪道探针联合D型硅胶管插管似乎是一种可行、微创、安全且有效的方法，可作为AD治疗的合理选择。
Zotero 插件